TACS•XL® DAB (diaminobenzidine) Kit


TACS•XL® DAB Kit is a complete kit for the in situ detection of DNA fragmentation.  This modified TUNEL assay  kit is based on the  incorporation of bromodeoxyuridine (BrdU) at the 3’ OH ends of the DNA fragments that are formed during apoptosis and a specific antibody to BrdU resulting in a high signal-to-noise ratio and less sensitivity to protease-induced false positive labeling than digoxigenin or biotin-based kits.


Available Size(s): 30 Samples Catalog Number: 4828-30-DK Categories: ,


TACS•XL® DAB Kit is designed for use with fixed frozen or paraffin embedded tissue sections.  All the reagents required for the labeling and detection of fragmented DNA and to assist in the identification of apoptotic morphologies are provided including two permeabilization reagents, labeling and detection reagents, stop buffers, DAB and Methyl Green counterstain as well as TACS-Nuclease™ for generating positive controls with your own samples.

Please refer to our components listing for details.



Material Safety Data Sheet(s)

msds_4800-30-01 Proteinase K

msds_4800-30-06 Strep-HRP

msds_4800-30-07 Diaminobenzidine

msds_4800-30-09 DAB Enhancer Reagent

msds_4800-30-15 TACS-Nuclease

msds_4800-30-16 TACS-Nuclease Buffer

msds_4800-30-18 1.0 Methyl Green

msds_4810-30-02 10X TdT Labeling Buffer

msds_4810-30-03 10X TdT Stop Buffer

msds_4810-30-05 TdT Enzyme

msds_4828-30-04 B dNTP Mix

msds_4828-30-06 Anti-BrdU Antibody

msds_4828-30-12 Strep-Diluent

msds_4876-05-01 Cytonin

Catalog # 4828-30-DK includes :
Catalog Number Description Qty
4800-30-01 Proteinase K 1
4800-30-06 Streptavidin-HRP 1
4800-30-07 Diaminobenzidine 1
4800-30-09 DAB Enhancer 1
4800-30-15 TACS-Nuclease™ 1
4800-30-16 TACS-Nuclease™ Buffer 1
4800-30-18 Methyl Green 1% 1
4810-30-02 TACS® 2 TdT Labeling Buffer 1
4810-30-03 TACS® 2 TdT Stop Buffer 1
4810-30-05 TdT Enzyme 1
4828-30-04 B-dNTP Mix 1
4828-30-06 anti-BrdU antibody 1
4828-30-12 Strep-Diluent 1
4876-05-01 Cytonin™ 1


Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma
Shao, R., Francescone, R., Ngernyuang, N., Bentley, B., Taylor, S.L., Moral, L., and Yan, W., Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma41671CarcinogenesisCarcinogenesis373
Carcinogenesis, Feb 2014; 35: 373 – 382

Hepatic Serum Amyloid A1 Aggravates T Cell-mediated Hepatitis by Inducing Chemokines via Toll-like Receptor 2 in Mice
“Young Rae Ji, Hei Jung Kim, Ki Beom Bae, Sanggyu Lee, Myoung Ok Kim, and Zae Young Ryoo”
J. Biol. Chem., May 2015; 290: 12804 – 12811.

Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma
Heather Francois-Vaughan, Adeola O. Adebayo, Kate E. Brilliant, Nicola M.A. Parry, Philip A. Gruppuso, and Jennifer A. Sanders
Carcinogenesis, Apr 2016; 37: 408 – 419.

“Mechanistic Target of Rapamycin (mTOR) Inhibition Synergizes with
Reduced Internal Ribosome Entry Site (IRES)-mediated Translation of
Cyclin D1 and c-MYC mRNAs to Treat Glioblastoma”

“Brent Holmes, Jihye Lee, Kenna A. Landon, Angelica Benavides-Serrato, Tariq Bashir, Michael E. Jung, Alan Lichtenstein, and Joseph Gera”
J. Biol. Chem., Jul 2016; 291: 14146 – 14159.